Enhanced in vitro inhibition of MCF-7 and magnetic properties of cobalt incorporated calcium phosphate (HAp and β-TCP) nanoparticles. Issue 1 (1st January 2023)

• Record Type: Journal Article
• Authors: Srinivasan, Baskar; Kolanthai, Elayaraja; Nivethaa, E.A.K.; Pandian, M. Senthil; Ramasamy, P.; Catalani, Luiz Henrique; Kalkura, S. Narayana
• Is Part Of: Ceramics international. Volume 49:Issue 1(2023)
• Page Start: 855
• Page End: 861
• Publication Date: 2023-01-01
• Subjects: Calcium phosphates -- Cobalt -- Magnetism -- MCF-7 inhibition; Ceramics -- Periodicals; Céramique industrielle -- Périodiques; Ceramics; Periodicals; Electronic journals; 666
• DOI: 10.1016/j.ceramint.2022.09.058
• Languages: English
• ISSNs: 0272-8842

Abstract

Abstract: The Co 2+ (0.1 M) incorporated hydroxyapatite (HAp) and beta tricalcium phosphate (β-TCP) nanoparticles were synthesized by the microwave assisted technique and sintering of HAp respectively. The samples were thermally treated at temperatures ranging from 200 to 1000°C. The partial substitutions of Co 2+ at the Ca 2+ site of HAp were confirmed from the slight shift (∼0.2°) in the (002) and (211) XRD peaks. The morphology of the nanoparticles was transformed from nanospheres to twinned particles on thermal treatment. In addition, the particle size of Co-600 was increased (from ∼50 nm to ∼100 nm) due to the recrystallization process. Further, the thermal treatment enhanced the crystallinity (41.15 to 90.16%), retentivity (Mr ) and coercivity (Hc ) of the nanoparticles. The cobalt incorporated HAp and β-TCP possessed paramagnetic property. The excellent bioactivity of β-TCP has been confirmed by the mineralization in simulated body fluid (SBF). Compared to HAp, β-TCP possessed better compatibility towards C2C12 cells on cobalt incorporation as evidenced by the in vitro cell viability. Moreover, both HAp and β-TCP have significantly inhibited the growth of MCF-7 on increasing the interaction time (72 h). Hence, the inhibition characteristics of Co 2+ incorporated calcium phosphate (CaP) towards MCF-7 (without affecting the normal cells) demonstrate its competency as a potential material for cancer therapy over the already existing nanoparticles.